Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: Association of DNA breaks with specific DNA motifs at PML and RARA loci

Syed Khizer Hasan, Tiziana Ottone, Richard F. Schlenk, Yuanyuan Xiao, Joseph L. Wiemels, Maria Enza Mitra, Paolo Bernasconi, Francesco Di Raimondo, Maria Teresa Lupo Stanghellini, Pepa Marco, Ashley N. Mays, Hartmut Döhner, Miguel A. Sanz, Sergio Amadori, David Grimwade, Francesco Lo-Coco

Research output: Contribution to journalArticle

Abstract

We compared genomic breakpoints at the PML and RARA loci in 23 patients with therapy-related acute promyelocytic leukemia (t-APL) and 25 de novo APL cases. Eighteen of 23 t-APL cases received the topoisomerase II poison mitoxantrone for their primary disorder. DNA breaks were clustered in a previously reported 8 bp "hot spot" region of PML corresponding to a preferred site of mitoxantrone-induced DNA topoisomerase II-mediated cleavage in 39% of t-APL occurring in patients exposed to this agent and in none of the cases arising de novo (P = 0.007). As to RARA breakpoints, clustering in a 3′ region of intron 2 (region B) was found in 65% of t-APL and 28% of de novo APL patients, respectively. Scan statistics revealed significant clustering of RARA breakpoints in region B in t-APL cases (P = 0.001) as compared to de novo APL (P = 1). Furthermore, ∼300 bp downstream of RARA region B contained a sequence highly homologous to a topoisomerase II consensus sequence. Biased distribution of DNA breakpoints at both PML and RARA loci suggest the existence of different pathogenetic mechanisms in t-APL as compared with de novo APL.

Original languageEnglish
Pages (from-to)726-732
Number of pages7
JournalGenes Chromosomes and Cancer
Volume49
Issue number8
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Acute Promyelocytic Leukemia
Nucleotide Motifs
DNA Breaks
Type II DNA Topoisomerase
Mitoxantrone
Cluster Analysis
Therapeutics
Poisons
Consensus Sequence
Sequence Homology
Introns
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia : Association of DNA breaks with specific DNA motifs at PML and RARA loci. / Hasan, Syed Khizer; Ottone, Tiziana; Schlenk, Richard F.; Xiao, Yuanyuan; Wiemels, Joseph L.; Mitra, Maria Enza; Bernasconi, Paolo; Raimondo, Francesco Di; Stanghellini, Maria Teresa Lupo; Marco, Pepa; Mays, Ashley N.; Döhner, Hartmut; Sanz, Miguel A.; Amadori, Sergio; Grimwade, David; Lo-Coco, Francesco.

In: Genes Chromosomes and Cancer, Vol. 49, No. 8, 08.2010, p. 726-732.

Research output: Contribution to journalArticle

Hasan, SK, Ottone, T, Schlenk, RF, Xiao, Y, Wiemels, JL, Mitra, ME, Bernasconi, P, Raimondo, FD, Stanghellini, MTL, Marco, P, Mays, AN, Döhner, H, Sanz, MA, Amadori, S, Grimwade, D & Lo-Coco, F 2010, 'Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: Association of DNA breaks with specific DNA motifs at PML and RARA loci', Genes Chromosomes and Cancer, vol. 49, no. 8, pp. 726-732. https://doi.org/10.1002/gcc.20783
Hasan, Syed Khizer ; Ottone, Tiziana ; Schlenk, Richard F. ; Xiao, Yuanyuan ; Wiemels, Joseph L. ; Mitra, Maria Enza ; Bernasconi, Paolo ; Raimondo, Francesco Di ; Stanghellini, Maria Teresa Lupo ; Marco, Pepa ; Mays, Ashley N. ; Döhner, Hartmut ; Sanz, Miguel A. ; Amadori, Sergio ; Grimwade, David ; Lo-Coco, Francesco. / Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia : Association of DNA breaks with specific DNA motifs at PML and RARA loci. In: Genes Chromosomes and Cancer. 2010 ; Vol. 49, No. 8. pp. 726-732.
@article{1e2f29aa2d6d45098b224ac9756d37a0,
title = "Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: Association of DNA breaks with specific DNA motifs at PML and RARA loci",
abstract = "We compared genomic breakpoints at the PML and RARA loci in 23 patients with therapy-related acute promyelocytic leukemia (t-APL) and 25 de novo APL cases. Eighteen of 23 t-APL cases received the topoisomerase II poison mitoxantrone for their primary disorder. DNA breaks were clustered in a previously reported 8 bp {"}hot spot{"} region of PML corresponding to a preferred site of mitoxantrone-induced DNA topoisomerase II-mediated cleavage in 39{\%} of t-APL occurring in patients exposed to this agent and in none of the cases arising de novo (P = 0.007). As to RARA breakpoints, clustering in a 3′ region of intron 2 (region B) was found in 65{\%} of t-APL and 28{\%} of de novo APL patients, respectively. Scan statistics revealed significant clustering of RARA breakpoints in region B in t-APL cases (P = 0.001) as compared to de novo APL (P = 1). Furthermore, ∼300 bp downstream of RARA region B contained a sequence highly homologous to a topoisomerase II consensus sequence. Biased distribution of DNA breakpoints at both PML and RARA loci suggest the existence of different pathogenetic mechanisms in t-APL as compared with de novo APL.",
author = "Hasan, {Syed Khizer} and Tiziana Ottone and Schlenk, {Richard F.} and Yuanyuan Xiao and Wiemels, {Joseph L.} and Mitra, {Maria Enza} and Paolo Bernasconi and Raimondo, {Francesco Di} and Stanghellini, {Maria Teresa Lupo} and Pepa Marco and Mays, {Ashley N.} and Hartmut D{\"o}hner and Sanz, {Miguel A.} and Sergio Amadori and David Grimwade and Francesco Lo-Coco",
year = "2010",
month = "8",
doi = "10.1002/gcc.20783",
language = "English",
volume = "49",
pages = "726--732",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia

T2 - Association of DNA breaks with specific DNA motifs at PML and RARA loci

AU - Hasan, Syed Khizer

AU - Ottone, Tiziana

AU - Schlenk, Richard F.

AU - Xiao, Yuanyuan

AU - Wiemels, Joseph L.

AU - Mitra, Maria Enza

AU - Bernasconi, Paolo

AU - Raimondo, Francesco Di

AU - Stanghellini, Maria Teresa Lupo

AU - Marco, Pepa

AU - Mays, Ashley N.

AU - Döhner, Hartmut

AU - Sanz, Miguel A.

AU - Amadori, Sergio

AU - Grimwade, David

AU - Lo-Coco, Francesco

PY - 2010/8

Y1 - 2010/8

N2 - We compared genomic breakpoints at the PML and RARA loci in 23 patients with therapy-related acute promyelocytic leukemia (t-APL) and 25 de novo APL cases. Eighteen of 23 t-APL cases received the topoisomerase II poison mitoxantrone for their primary disorder. DNA breaks were clustered in a previously reported 8 bp "hot spot" region of PML corresponding to a preferred site of mitoxantrone-induced DNA topoisomerase II-mediated cleavage in 39% of t-APL occurring in patients exposed to this agent and in none of the cases arising de novo (P = 0.007). As to RARA breakpoints, clustering in a 3′ region of intron 2 (region B) was found in 65% of t-APL and 28% of de novo APL patients, respectively. Scan statistics revealed significant clustering of RARA breakpoints in region B in t-APL cases (P = 0.001) as compared to de novo APL (P = 1). Furthermore, ∼300 bp downstream of RARA region B contained a sequence highly homologous to a topoisomerase II consensus sequence. Biased distribution of DNA breakpoints at both PML and RARA loci suggest the existence of different pathogenetic mechanisms in t-APL as compared with de novo APL.

AB - We compared genomic breakpoints at the PML and RARA loci in 23 patients with therapy-related acute promyelocytic leukemia (t-APL) and 25 de novo APL cases. Eighteen of 23 t-APL cases received the topoisomerase II poison mitoxantrone for their primary disorder. DNA breaks were clustered in a previously reported 8 bp "hot spot" region of PML corresponding to a preferred site of mitoxantrone-induced DNA topoisomerase II-mediated cleavage in 39% of t-APL occurring in patients exposed to this agent and in none of the cases arising de novo (P = 0.007). As to RARA breakpoints, clustering in a 3′ region of intron 2 (region B) was found in 65% of t-APL and 28% of de novo APL patients, respectively. Scan statistics revealed significant clustering of RARA breakpoints in region B in t-APL cases (P = 0.001) as compared to de novo APL (P = 1). Furthermore, ∼300 bp downstream of RARA region B contained a sequence highly homologous to a topoisomerase II consensus sequence. Biased distribution of DNA breakpoints at both PML and RARA loci suggest the existence of different pathogenetic mechanisms in t-APL as compared with de novo APL.

UR - http://www.scopus.com/inward/record.url?scp=77953522671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953522671&partnerID=8YFLogxK

U2 - 10.1002/gcc.20783

DO - 10.1002/gcc.20783

M3 - Article

C2 - 20544846

AN - SCOPUS:77953522671

VL - 49

SP - 726

EP - 732

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 8

ER -